This article is more than 5 years old. Information may no longer be current.
SAMHSA, CDC announce funding to address opioid epidemic in rural US
Click Here to Manage Email Alerts
The Substance Abuse and Mental Health Services Administration recently announced a new federal funding opportunity to address the opioid use and overdose epidemic and associated comorbidities in rural U.S. regions.
Funding will go towards research on comprehensive, integrated approaches to prevent opioid injection and related consequences, including substance use disorder, overdose, HIV, hepatitis C and associated conditions such as hepatitis B and STDs.
The initiative will focus on coal-impacted counties within Appalachia and other rural communities across the country.
The request for applications titled “HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment, and Control (UG3/UH3)” is funded by the National Institute on Drug Abuse in collaboration with the Appalachian Regional Commission, the CDC and SAMHSA.
An accompanying request for application, titled Hepatitis C Virus Advanced Molecular Detection in Support of System for Prevention, Treatment, and Control of HIV, HCV, and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States (U24), will fund a center for next-generation sequencing for HCV using Global Hepatitis Outbreak Surveillance and Technology.